FDA questions Takeda & more: 5 GI industry key notes

Here are five updates from gastroenterology companies and practices from the past week:

Advertisement

The FDA sent Takeda a questioning letter in response to the company’s biologics license application concerning the subcutaneous formulation of Entyvio, a maintenance therapy for ulcerative colitis.

Baptist Medical Center in Jacksonville, Fla., built what it believes to be the region’s first gastroesophageal reflux center.

South Denver Gastroenterology opened a clinic and endoscopy center in Castle Rock, Colo.

Conmed is leaving the NASDAQ and transferring its listing to the New York Stock Exchange.

Minneapolis-based Colon & Rectal Surgery Associates will join Infinite Health Collaborative in the spring.

More articles on surgery centers: 
Holly Springs Surgery Center renews accreditation
The Joint Commission releases new requirements for total knee & hip certification
California medical board OKs outpatient surgery accreditation program

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.